A SECRET WEAPON FOR SEVITERONEL TNBC

-mutated tumors. Even so, just a fraction of these people responds to immune checkpoint or PARP inhibitors and in many cases individuals that do react generally create resistance and relapse.Mechanistically, we report differential binding of AR to focus on genes within the presence of enzalutamide and seviteronel, suggesting diverse mechanisms of m